Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor kcyB (NF-kcyB) and Extracellular Signal-regulated kinase 1 and 2 (ERK1/2) and Mitogen Stress activated kinase 1 (MSK1) signaling.
Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.
Firategrast: natalizumab in a pill?
Comparative efficacy of switching to natalizumab in active multiple sclerosis.
Cuprizone demyelination of the corpus callosum in mice correlates with altered social interaction and impaired bilateral sensorimotor coordination.
Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone.
Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis.
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: Yes.
White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.
GlaxoSmithKline Product Development Pipeline
Frequency and magnitude of interferon β neutralizing antibodies in the evaluation of interferon β immunogenicity in patients with multiple sclerosis.
Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis.
Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis.
Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination.
Mitoxantrone - an anthraquinone antibiotic with antitumor activity applied for the treatment of multiple sclerosis.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail?
Clinical Characteristics of Pediatric-Onset and Adult-Onset Multiple Sclerosis in Hispanic Americans.
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
The quality of reports of randomized trials in multiple sclerosis: a review.
High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies.
Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Mechanism of action of mitoxantrone.
Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies.
Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis.
Pages
« first
‹ previous
…
21
22
23
24
25
26
27
28
29
…
next ›
last »